Role of Gut Microbiota on Cardio-Metabolic Parameters and Immunity in Coronary Artery Disease Patients with and without Type-2 Diabetes Mellitus

Abstract

Gut microbiota composition has been reported as a factor linking host metabolism with the development of cardiovascular diseases (CVD) and intestinal immunity. Such gut microbiota has been shown to aggravate CVD by contributing to the production of trimethylamine N-oxide (TMAO), which is a pro-atherogenic compound. Treg cells expressing the transcription factor Forkhead box protein P3 (FoxP3) play an essential role in the regulation of immune responses to commensal microbiota and have an atheroprotective role. However, the aim of this study was to analyze the role of gut microbiota on cardio-metabolic parameters and immunity in coronary artery disease (CAD) patients with and without type-2 diabetes mellitus (DM2). The study included 16 coronary CAD-DM2 patients, and 16 age, sex, and BMI matched CAD patients without DM2 (CAD-NDM2). Fecal bacterial DNA was extracted and analyzed by sequencing in a GS Junior 454 platform followed by a bioinformatic analysis (QIIME and PICRUSt). The present study indicated that the diversity and composition of gut microbiota were different between the CAD-DM2 and CAD-NDM2 patients. The abundance of phylum Bacteroidetes was lower, whereas the phyla Firmicutes and Proteobacteria were higher in CAD-DM2 patients than those in the CAD-NDM2 group. CAD-DM2 patients had significantly less beneficial or commensal bacteria (such as Faecalibacterium prausnitzii and Bacteroides fragilis) and more opportunistic pathogens (such as Enterobacteriaceae, Streptococcus, and Desulfovibrio). Additionally, CAD-DM2 patients had significantly higher levels of plasma zonulin, TMAO, and IL-1B and significantly lower levels of IL-10 and FOXP3 mRNA expression than CAD-NDM2. Moreover, in the CAD-MD2 group, the increase in Enterobacteriaceae and the decrease in Faecalibacterium prausnitzii were significantly associated with the increase in serum TMAO levels, while the decrease in the abundance of Bacteroides fragilis was associated with the reduction in the FOXP3 mRNA expression, implicated in the development and function of Treg cells. These results suggest that the presence of DM2 is related to an impaired regulation of the immune system in CAD patients, mediated in part by the gut microbiota composition and functionality and the production and effects of their gut microbiota derived molecules.

Gut microbe–generated metabolite trimethylamine N‐oxide and the risk of diabetes: A systematic review and dose‐response meta‐analysis

“…Our meta‐analysis of continuous variables of the relationship between TMAO concentration and DM risk included 5330 participants from five studies in which all samples were plasma. We calculated the SMD of TMAO levels in DM and non‐DM populations after unit conversion.…”

Insights into the bacterial symbiont diversity in spiders

“…Our results showed that the abundance of endosymbionts and other bacteria inside the bodies of different spider species was different. It is well‐known that research on gut bacteria of invertebrate and vertebrate animals is increasing because of their potential function on their hosts (Berasategui et al., ; Sanchez‐Alcoholado et al., ; Smith, Srygley, Healy, Swaminath, & Mueller, ). Spiders have a special feeding mode.…”

Gut microbiota‐derived metabolite trimethylamine N‐oxide (TMAO) potentially increases the risk of obesity in adults: An exploratory systematic review and dose‐response meta‐ analysis

“…Egg yolks, milk, dairy products, organ and muscle meats, and seafood such as mollusks, crustaceans, and fish are major dietary sources of TMAO and its precursors, although whether circulating TMAO is affected by dietary source needs to be further evaluated . There are numerous studies regarding the association between TMAO and biomarkers or risk factors of CVD, increased insulin resistance, impaired glucose metabolism, and metabolic syndrome . Possible suggested mechanisms about the association between TMAO and cardiovascular risk factors could be increased cholesterol accumulation in macrophages and in foam cells of artery walls or increased human platelet hyper‐responsiveness and potential of thrombosis in higher TMAO concentrations.…”